August 25, 2016 1:51 PM ET


Company Overview of Genentech, Inc.

Key Executives for Genentech, Inc.

NameBoard RelationshipsTitleAge
Ian T. Clark 165 RelationshipsChief Executive Officer, Head of North American Commercial Operations and Director55
Herbert W. Boyer Ph.D.30 RelationshipsCo-Founder and Member of Scientific Resource Board79
Anthony P. Adamis M.D.No RelationshipsVice President and Global Head of Ophthalmology57
Andrew C. Chan M.D., Ph.D.No RelationshipsSenior Vice President of Research Biology56
Sandra J. Horning M.D.7 RelationshipsChief Medical Officer, Head of Global Product Development and Executive Vice President of Global Development 67
View More Key Executives

Genentech, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Severin Schwan Ph.D. 46 RelationshipsRoche Holding AG49
Ian T. Clark 165 RelationshipsGenentech, Inc.55
Herbert W. Boyer Ph.D. 30 RelationshipsGenentech, Inc.79
John Irving Bell B.E. 72 RelationshipsGHO Capital Partners LLP64
Andre S. Hoffmann A.C., D.E. 60 RelationshipsInovalon Holdings, Inc.58
View All Board Members

Genentech, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation$13.2M
Not meaningful
Total Value of Options$998.0K
Compensation as of Fiscal Year 2005
Genentech, Inc. CEO Compensation
Industry Average


OptiBiotix Health plc Announces Executive Changes
August 25, 2016 6:00 AM ET
Pacific Edge Limited Announces Board Changes
August 25, 2016 2:34 AM ET
BeiGene, Ltd. Appoints Amy Peterson as Chief Medical Officer, Immuno-Oncology
August 24, 2016 8:15 PM ET
Franco Valle Assumes as Interim Principal Accounting Officer of Lion Biotechnologies, Inc
August 24, 2016 8:08 PM ET
TxCell SA Appoints Olivier Danos to its Scientific Advisory Board
August 24, 2016 3:45 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genentech, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at